Rhazdrugs’ most significant and beneficial feature is its ability to integrate directly into an Electronic Health Record (EHR). Our product metrics show that nurses and clinicians are nearly twice as likely to access vital hazardous drug safety information when it is accessible directly from the EHR compared to when it is not. This can be critical in patient outcomes and healthcare worker safety.
Laura Paxton
Recent Posts
How Rhazdrugs Integration with Cerner Transformed One Healthcare System
Welcome to the Rpharmy School of Hard Knocks, where we wholeheartedly believe that embracing the successes and challenges of others enhances our learning!
At Rpharmy, our solutions are deployed across hundreds of hospitals. Through our collaborative relationships with these institutions, we have gained deep insights into their challenges and wins. These five lessons learned during the USP <800> compliance process have percolated to the top through these relationships. We hope these insights help as you continue the critical work of protecting healthcare workers from the dangerous effects of hazardous drug exposure.
Press Release: Rpharmy Overhauls BlackboxRX User Experience, Interface
Medication Safety Solution Provider Significantly Upgrades Only Comprehensive Online Database of Medication Boxed Warnings
20 Years Strong: BlackboxRX’s User Experience Evolution
A few weeks ago, we wrote about our quest to improve the user experience across our software. Now we’re back to let you know that our new and improved BlackboxRX is live!
A User Experience Overhaul: Rpharmy’s Quest to Improve Healthcare Safety
Our #1 highest priority is improving patient outcomes and the health and well-being of healthcare workers. We accomplish this by making your critical job easier through easy-to-use but in-depth safety information platforms. We never see our job as complete in this area and are always working for you.
In the last few years, we’ve focused on ensuring our products meet your USP <800> compliance and medication safety needs by ramping up the drug monograph and safety information. More recently, we recognized a need to improve the user experience (UX) of our solutions, enhancing the look, feel, and functionality of our products. We embarked on an extensive UX project with Ix (pronounced Nine), a talented user experience designer. From seemingly minor customer requests to our latest UX endeavor, it’s all for you!
Press Release: Rpharmy Awarded Drug Information and Surveillance Solutions Agreement With Premier, Inc.
Formulary Management, Hazardous Drugs Safety Information SaaS Provider Joins Group Purchasing Organization to Help Improve Patient, Healthcare Worker Safety
Rpharmy Awarded Drug Information and Surveillance Agreement with Premier Group Purchasing Organization
We are thrilled to announce that Rpharmy has been awarded a national group purchasing agreement for Drug Information and Surveillance Solutions with Premier Inc., a group purchasing organization, in a shared mission to enhance patient and healthcare worker safety through the use of Rhazdrugs and Formweb. This partnership underscores our collective commitment to improving healthcare outcomes.
Enhancing Healthcare Safety: Customizing Hazardous Drug Protocols to Include Illicit Drug Exposure
Every hospital or healthcare facility is distinctive in two critical ways concerning hazardous drugs: their unique hazardous drugs list and how they communicate the safety information related to those drugs. Of course, there are regulations and requirements like USP <800> and NIOSH lists, etc., that dictate aspects of the list or the communication requirements, but outside of those standards, organizations have room to customize for their needs.
One of those unique needs is to identify and communicate safety protocols to protect healthcare workers from unintentional occupational exposure to “illicit drugs” or what other organizations refer to as “street drugs.”
The Power of Women-Owned Business Certifications: Rpharmy is Texas HUB Certified
In 2023, Medical Design & Outsourcing reported just 23.1% of medtech industry CEOs were women, up from 21.8% in 2022. While the percentage of women in C-suite roles in the medtech industry continues to inch its way up, the industry still has a long way to go in promoting women's leadership.
This is one of many reasons why it is vital for women-owned businesses - especially in all aspects of healthcare - to seek the available certifications and promote talented, intelligent, hard-working women within their organizations.
I practice what I preach and am proud to announce that Rpharmy has recently received certification in the Texas Historically Underutilized Business (HUB) Program. The HUB Program is a state initiative designed to promote opportunities for businesses owned by minorities and women in the area of state procurement and contracting. It provides various opportunities for women-owned businesses to garner the attention of state agencies and consideration for upcoming contracts.
The Future of Rpharmy: Building a Legacy of Safety in Healthcare
To our long-time Rpharmy supporters and new acquaintances alike, we express our heartfelt gratitude for your continued trust and partnership. As our network has grown through recent events, online encounters, and customer referrals, we realize it's time to re-introduce the driving force behind our work. Plus, we have some exciting updates about our team to share with you. Read on!

